186 related articles for article (PubMed ID: 26526191)
1. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials.
Castillo JJ; Mulkey F; Geyer S; Kolitz JE; Blum W; Powell BL; George SL; Larson RA; Stone RM
Am J Hematol; 2016 Feb; 91(2):199-204. PubMed ID: 26526191
[TBL] [Abstract][Full Text] [Related]
2. Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.
Tavitian S; Denis A; Vergez F; Berard E; Sarry A; Huynh A; Delabesse E; Luquet I; Huguet F; Récher C; Bertoli S
Am J Hematol; 2016 Feb; 91(2):193-8. PubMed ID: 26509505
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
[TBL] [Abstract][Full Text] [Related]
5. A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.
Crysandt M; Kramer M; Ehninger G; Bornhäuser M; Berdel WE; Serve H; Röllig C; Kaifie A; Jost E; Brummendorf TH; Wilop S
Eur J Haematol; 2016 Jul; 97(1):17-24. PubMed ID: 26277604
[TBL] [Abstract][Full Text] [Related]
6. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
[TBL] [Abstract][Full Text] [Related]
8. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
Head DR; Kopecky KJ; Willman C; Appelbaum FR
Leukemia; 1994; 8 Suppl 2():S38-41. PubMed ID: 7815835
[TBL] [Abstract][Full Text] [Related]
10. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Feng X; Lan H; Ruan Y; Li C
Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
[TBL] [Abstract][Full Text] [Related]
11. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup.
Büchner T; Schlenk RF; Schaich M; Döhner K; Krahl R; Krauter J; Heil G; Krug U; Sauerland MC; Heinecke A; Späth D; Kramer M; Scholl S; Berdel WE; Hiddemann W; Hoelzer D; Hehlmann R; Hasford J; Hoffmann VS; Döhner H; Ehninger G; Ganser A; Niederwieser DW; Pfirrmann M
J Clin Oncol; 2012 Oct; 30(29):3604-10. PubMed ID: 22965967
[TBL] [Abstract][Full Text] [Related]
12. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and treatment outcomes in 822 adult patients with acute myeloid leukemia:a single center experience].
Lin D; Zhou C; Wei H; Liu B; Wang Y; Liu K; Li W; Gong B; Wang J; Wei S; Zhang G; Zhao X; Li Y; Liu Y; Gong X; Sun M; Lu Y; Mi Y; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1058-64. PubMed ID: 25543697
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
15. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
16. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.
Estey E; Thall P; Kantarjian H; Pierce S; Kornblau S; Keating M
Leukemia; 1997 Oct; 11(10):1661-4. PubMed ID: 9324286
[TBL] [Abstract][Full Text] [Related]
17. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
[TBL] [Abstract][Full Text] [Related]
18. The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan.
Yeh TC; Liu HC; Wang LY; Chen SH; Lin WY; Liang DC
J Pediatr Hematol Oncol; 2007 Dec; 29(12):826-31. PubMed ID: 18090930
[TBL] [Abstract][Full Text] [Related]
19. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
20. Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study.
Reagan JL; Sullivan MR; Winer ES; Lansigan F; Cardin MS; Castillo JJ
Leuk Res; 2015 Aug; 39(8):812-7. PubMed ID: 26045177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
